Recombinant human IL-16 inhibits HIV-1 replication and protects against activation-induced cell death (AICD)

Clinical and Experimental Immunology

Volumn 112, Issue 1, 1998, Pages 84-91

  Idziorek, T ^a   Khalife, J ^a   Billaut Mulot, O ^a   Hermann, E ^a   Aumercier, M ^b   Mouton, Y ^c   Capron, A ^a   Bahr, G M ^a  

^a INSTITUT PASTEUR DE LILLE   (France)

^b CNRS   (France)

^c CENTRE HOSPITALIER DE TOURCOING   (France)

Author keywords

Apoptosis; HIV 1 replication; IL 16

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN; CHEMOATTRACTANT; DEXAMETHASONE; FAS ANTIGEN; INTERLEUKIN 16; INTERLEUKIN 2; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; PHYTOHEMAGGLUTININ; PROTEINASE INHIBITOR; RECOMBINANT CYTOKINE; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CELL DEATH; CONTROLLED STUDY; CROSS LINKING; ESCHERICHIA COLI; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE STATUS; IMMUNOMODULATION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; VIRUS INHIBITION;

APOPTOSIS; CELLS, CULTURED; ESCHERICHIA COLI; HIV INFECTIONS; HIV-1; HUMANS; INTERLEUKIN-16; LEUKOCYTES, MONONUCLEAR; RECOMBINANT PROTEINS; VIRUS REPLICATION;

EID: 0031967966     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1998.00550.x     Document Type: Article

References (47)

1. Meyaard L, Otto SA, Jonker RR, Mijnster MJ, Keet RPM, Miedema F. Programmed death of T cells in HIV-1 infection. Sci 1992; 257:217-9.
2. + T cells from human immunodeficiency virus-infected asymptomatic individuals. J Exp Med 1992; 175:331-40.
3. Banda NK, Bernier J, Kurahara DK, Kurrle R, Haigwood N, Sekaly RP, Finkel TH. Crosslinking CD4 by human immunodeficiency virus gp120 primes T cells for activation-induced apoptosis. J Exp Med 1992; 176:1099-106.
4. Westendorp MO, Frank R, Ochsenbauer C, Stricker K, Dhein J, Walczak H, Debatin KM, Krammer PH. Sensitization of T cells to CD95-mediated apoptosis by HIV-1 tat and gp120. Nature 1995; 375: 497-500.
5. Finkel TH, Tudor-Williams G, Banda NK et al. Apoptosis occurs predominantly in bystander cells and not in productively infected cells of HIV- and SIV-infected lymph nodes. Nature Med 1995; 1:129-34.
6. Muro-Cacho CA, Pantaleo G, Fauci AS. Analysis of apoptosis in lymph nodes of HIV-infected persons: Intensity of apoptosis correlates with the general state of activation of the lymphoid tissue and not with stage of disease or viral burden. J Immunol 1995; 154:5555-66.
7. Pandolfi F, Pierdominici M, Oliva A et al. Apoptosis-related mortality in vitro of mononuclear cells from patients with HIV infection correlates with disease severity and progression. J Acquir Immune Defic Syndr Hum Retrovirol 1995; 9:450-8.
8. Gougeon ML, Lecoeur H, Dulioust A, Enouf MG, Crouvoisier M, Goujard C, Debord T, Montagnier L. Programmed cell death in peripheral lymphocytes from HIV-infected persons: Increased susceptibility to apoptosis of CD4 and CD8 T cells correlates with lymphocyte activation and with disease progression. J Immunol 1996; 156:3509-20.
9. Carbonari M, Cibati M, Pesce AM, Sbarigia D, Grossi P, D'Offizi G, Luzi G, Fiorilli M. Frequency of provirus-bearing CD4+ cells in HIV type 1 infection correlates with extent of in vitro apoptosis of CD8+ but not CD4+ cells. AIDS Res Hum Retrovir 1995; 11:789-94.
10. Gougeon ML, Garcia S, Heeney J et al. Programmed cell death in AIDS-related HIV and SIV infections. AIDS Res Hum Retrovir 1993; 9:553-63.
11. Clerici M, Sarin A, Coffman RL et al. Type 1/type 2 cytokine modulation of T cell programmed cell death as a model for human immunodeficiency virus pathogenesis. Proc Natl Acad Sci USA 1994; 91:11811-5.
12. Estaquier J, Idziorek T, Zou W, Emilie D, Farber CM, Bourez JM, Ameisen JC. T helper type 1/T helper type 2 cytokines and T cell death: preventive effect of interleukin 12 on activation-induced and CD95 (Fas/APO-1) -mediated apopotosis of CD4+ T cells from human immunodeficiency virus-infected persons. J Exp Med 1995; 182: 1759-67.
13. Sloand EM, Young NS, Kumar P, Weichold PF, Sato T, Maciejewski JP. Role of Fas ligand and receptor in the mechanism of T cell depletion in acquired immunodeficiency syndrome: effect on CD4+ lymphocyte depletion and human immunodeficiency virus replication. Blood 1997; 89:1357-63.
14. Oyaizu N, Adachi Y, Hashimoto F, McCloskey TW, Hosaka N, Kayagaki N, Yagita H, Pahwa S. Monocytes express Fas ligand upon CD4 cross-linking and induce CD4+ T cells apoptosis: a possible mechanism of bystander cell death in HIV infection. J Immunol 1997; 158:2456-63.
15. Center DM, Kornfeld H, Cruikshank WW. Interleukin-16 and its function as a CD4 ligand. Immunol Today 1996; 17:476-81.
16. Cruikshank WW, Lim K, Theodore AC, Cook J, Fine G, Weller PF, Center DM. IL-16 inhibition of CD3-dependent lymphocyte activation and proliferation. J Immunol 1996; 157:5240-8.
17. Baier M, Werner A, Bannert N, Metzner K, Kurth R. HIV suppression by interleukin-16. Nature 1995; 378:563.
18. Zhou P, Goldstein S, Devadas K, Tewari D, Notkins AL. Human CD4+ cells transfected with IL-16 cDNA are resistant to HIV-1 infection: inhibition of mRNA expression. Nature Med 1997; 3:659-64.
19. Cruikshank WW, Center DM, Nisar N, Wu M, Natke B, Theodore AC, Kornfeld H. Molecular and functional analysis of a lymphocyte chemoattractant factor: association of biologic function with CD4 expression. Proc Natl Acad Sci USA 1994; 91:5109-13.
20. Idziorek T, Estaquier J, De Bels F, Ameisen JC. YOPRO-1 allows cytofluorometric analysis of programmed cell death (apoptosis) without interfering with living cell viability. J Immunol Methods 1995; 185: 249-58.
21. Rey MA, Spire B, Dormont D, Barré-Sinoussi F, Montagnier L, Chermann JC. Characterization of the RNA dependent DNA polymerase of a new human T-lymphotropic retrovirus (lymphodenopathy associated virus). Biochem Biophys Res Commun 1984; 121:126-33.
22. Choe H, Farzan M, Sun Y et al. The β-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell 1996; 85:1135-48.
23. Feng Y, Broder CC, Kennedy PE, Berger EA. HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science 1996; 272:872-7.
24. Cocchi F, DeVico AL, Garzino-Demo A, Arya SK, Gallo RC, Lusso P. Identification of RANTES, MIP-1α and MIP-1β as the major HIV-suppressive factors produced by CD8+ T cells. Science 1995; 270:1811-5.
25. Bleul CC, Farzan M, Choe H, Parolin C, Clark-Lewis I, Sodroski J, Springer TA. The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry. Nature 1996; 382:829-33.
26. Mackewicz CE, Levy JA, Cruikshank WW, Kornfeld H, Center DM. Role of IL-16 in HIV replication. Nature 1996; 383:488-9.
27. Maciaszek JW, Parada NA, Cruikshank WW, Center DM, Kornfeld H, Viglianti GA. IL-16 represses HIV-1 promoter activity. J Immunol 1997; 158:5-8.
28. Baier M, Bannert N, Werner A, Lang K, Kurth R. Molecular cloning, sequence, expression, and processing of the interleukin 16 precursor. Proc Natl Acad Sci USA 1997; 94:5273-7.
29. Oyaizu N, McCloskey TW, Coronesi M, Chirmule N, Kalyanaraman VS, Pahwa S. Accelerated apoptosis in peripheral blood mononuclear cells (PBMCs) from human immunodeficiency virus type-1 infected patients and in CD4 cross-linking PBMCs from normal individuals. Blood 1993; 82:3392-400.
30. Oyaizu N, McCloskey TW, Than S, Hu R, Kalyanaraman VS, Pahwa S. Cross-linking of CD4 molecules upregulates Fas antigen expression in lymphocytes by inducing interferon-γ and tumor necrosis factor-α secretion. Blood 1994; 84:2622-31.
31. Yoo J, Chen H, Kraus T, Hirsch D, Polyak S, George I, Sperber K. Altered cytokine production and accessory cell function after HIV-1 infection. J Immunol 1996; 157:1313-20.
32. Accornero P, Radrizzani M, Delia D, Gerosa F, Kurrle R, Colombo MP. Differential susceptibility to HIV-GP120-sensitized apoptosis in CD4+ T cell clones with different T-helper phenotypes: role of CD95/CD95L interactions. Blood 1997; 89:558-69.
33. Newell MK, Haughn LJ, Maroun CR, Julius MH. Death of mature T cells by separate ligation of CD4 and the T cell receptor of antigen. Nature 1990; 347:286-9.
34. Oyaizu N, McCloskey TW, Than S, Pahwa S. Inhibition of CD4 cross-linking-induced lymphocytes apoptosis by vesnarinone as a novel immunomodulating agent: vesnarinone inhibits Fas expression and apoptosis by blocking cytokine secretion. Blood 1996; 87:2361-8.
35. Clouse KA, Casentino LM, Weih KA, Pyle SW, Robbins PB, Hochstein HD, Natarajan V, Farrar WL. The HIV-1 gp120 envelope protein has the intrinsic capacity to stimulate monokine secretion. J Immunol 1991; 147:2892-901.
36. Jabado N, Le Deist F, Fischer A, Hivroz C. Interaction of HIV, gp120 and anti-CD4 antibodies with the CD4 molecule on human CD4+ T cells inhibits the binding activity of NF-AT, NF-χB and AP-1, three nuclear factors regulating interleukin-2 gene enhancer activity. Eur J Immunol 1994; 24:2646-52.
37. Baldari CT, Milia E, Di Somma MM, Baldoni F, Valitutti S, Telford JL. Distinct signaling properties identify functionally different CD4 epitopes. Eur J Immunol 1995; 25:1843-50.
38. Cordiali Fei P, Solmone M, Viora M, Vanacore P, Pugliese O, Giglio A, Caprilli E, Ameglio E. Apoptosis in HIV-infection: protective role of IL-2. J Biol Regul Homeost Agents 1994; 8:60-64.
39. Benkirane MD, Corbeau P, Housse TV, Deveaux C. An antibody that binds the immunoglobulin CDR3-like region of the CD4 molecule inhibits provirus transcription in HIV-infected T cells. EMBO J 1993; 12:4909-12.
40. Tremblay M, Meloche S, Gratton S, Wainberg MA, Sekaly RP. Association of P56-lck with the cytoplasmic domain of CD4 modulates HIV-1 expression. EMBO J 1994; 13:774-83.
41. Katsikis PD, Garcia-Ojeda ME, Torres-Roca JF, Greenwald DR, Herzenberg LA, Herzenberg LA. HIV type 1 tat protein enhances activation-but not Fas (CD95)-induced peripheral blood T cell apoptosis in healthy individuals. Int Immunol 1997; 9:835-41.
42. Moreno MB, Memon SA, Zacharchuk CM. Apoptosis signaling pathways in normal T cells: differential activity of Bcl-2 and IL-1beta-converting enzyme family protease inhibitors on glucocorticoid- and Fas-mediated cytotoxicity. J Immunol 1996; 157:3845-9.
43. Kovacs B, Vassilopoulos D, Vogelgesang SA, Tsokos GC. Defective CD3-mediated cell death in activated T cells from patients with systemic lupus erythematosus: role of decreased intracellular TNF-α. Clin Immunol Immunopathol 1996; 81:293-302.
44. Gougeon ML, Lecoeur H, Boudet F et al. Lack of chronic immune activation in HIV-infected chimpanzees correlates with the resistance of T cells to Fas/Apo-1 (CD95)-induced apoptosis and preservation of a T helper phenotype. J Immunol 1997; 158:2964-76.
45. Rothen M, Gratzel S, Hirsch HH, Moroni C. Apoptosis in HIV-infected individuals is an early marker occurring independently of high viremia. AIDS Res Hum Retrovir 1997; 13:771-9.
46. Autran B, Carcelain G, Li TS et al. Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease. Science 1997; 277:112-6.
47. Böhler T, Herr I, Debatin KM, Geiss M, Haas J. Downregulation of increased CD95 (APO-1/Fas) ligand in T cells from human immunodeficiency virus-type 1-infected children after antiretroviral therapy. Blood 1997; 90:886-7.